You are here:Home-Chemical Inhibitors & Agonists-Nuclear Receptor/Transcription Factor-Keap1-Nrf2-S217879
S217879

Chemical Structure : S217879

CAS No.: 2700303-28-0

S217879 (S 217879, CAS 2700303-28-0)

Catalog No.: PC-20065Not For Human Use, Lab Use Only.

S217879 (S 217879) is a highly potent and selective NRF2 activator, binds to KEAP1 Kelch domain (SPR Kd=4.15 nM), disrupts the KEAP1-NRF2 interaction leading to robust NRF2 pathway activation.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    S217879 (S 217879) is a highly potent and selective NRF2 activator, binds to KEAP1 Kelch domain (SPR Kd=4.15 nM), disrupts the KEAP1-NRF2 interaction leading to robust NRF2 pathway activation.
    S217879 displays high selectivity for KEAP1 binding in a broad selectivity panel comprising 110 targets at 10 uM.
    S217879 significantly activated a reporter gene driven by an ARE in HepG2 cells in a concentration-dependent manner with an EC50 of 18 nM, reduced H2O2-stimulated ROS production in HepG2 cells.|
    In hPBMCs, S217879 treatment for 6 h resulted in a concentration-dependent increase in Nqo1 gene expression with an EC50 of 16 nM.
    Pretreatment for 4 h with S217879 led to a significant and concentration-dependent inhibition of LPS-induced cytokine release as measured by IL1β, MCP-1 and IL6 MagPix multiplex assays.
    S217879 (30 mg/kg, PO, QD) reduced NASH progression in MCDD mice in a dose-dependent manner, reduced NASH progression and liver fibrosis in DIO NASH mice model.

    Physicochemical Properties

    M.Wt 578.64
    Formula C29H30N4O7S
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20°C 12 Months; 4°C 6 Months
    In Solvent
    -80°C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    2-((2R,4S)-54,2-dimethyl-12,12-dioxido-13,14-dihydro-51H-8,11-dioxa-1(3,6)-benzo[e][1,2,3]oxathiazina-5(6,1)-benzo[d][1,2,3]triazola-3(1,3)-benzenacycloundecaphane-4-yl)acetic acid

    References

    1. Klaus Seedorf, et al. JHEP Rep. 2022 Dec 16;5(4):100651.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: